Articles NewsFlow Gold & Silver Prices Market Briefing

Recevez notre Marketbriefing

In the same category
Gold, Miners Overboughtness Adam Hamilton Gold’s Remarkable Breakout Adam Hamilton Gold Miners’ Q1’24 Preview Adam Hamilton Debt Collapse and Monetary Reset Part 1 Hubert Moolman Silver And The Coming Monetary Reform Hubert Moolman Debt Collapse and Monetary Reset Cycle (shor... Hubert Moolman Gold’s Pullback and Miners Adam Hamilton Gold’s Major Signal Breakout Hubert Moolman

overtheedge
Member since May 2012
680 commentaries - 6 followers

6 followers

has posted a comment on the article :

Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn - The Life Sciences Report -

Who is going to pay these prices for the treatment?
Perhaps the 1%ers might have the income stream, but what percentage of them will need it?
Now factor in the length of drug patent rights.

All I see is a pump and dump.
The majors eventually buy the minors to acquire all the research and then write the cost off against taxes.
Never argue with success.

Commented 3364 days ago

Send

Beginning of the headline :Immuno-oncology—disabling cancer's defenses so that a patient's own immune system can seek it out and destroy it—took center stage in the drug development world in 2014. Stephen Dunn of LifeTech Capital believes that preeminence will continue in 2015, bolstered by new drug approvals, new targets and new combination immunotherapies that increase potency. In this interview with The Life Sciences Report, Dunn outlines how companies large and small are leveraging these therapies, and where investors... Read More

Reply to this comment

You must be logged in to comment an article

8000 characters max.

	RSS feed		24hGold Mobile
	Gold Data Center		Gold & Silver Converter
	Gold coins on eBay		Silver coins on eBay
	Technical Analysis		Fundamental Analysis